COPD exacerbations: targeting IL-33 as a new therapy

Affiliations

• ¹ Centre for Inflammation, Centenary Institute, and University of Technology Sydney, Faculty of Science, Sydney, NSW 2050, Australia; Priority Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia.
• ² Woolcock Institute of Medical Research, University of Sydney and School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia.
• ³ Priority Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia.
• ⁴ Centre for Inflammation, Centenary Institute, and University of Technology Sydney, Faculty of Science, Sydney, NSW 2050, Australia; Priority Centre for Healthy Lungs, Hunter Medical Research Institute and The University of Newcastle, Newcastle, NSW, Australia. Electronic address: chantal.donovan@uts.edu.au.